loadpatents
name:-0.03535795211792
name:-0.020838975906372
name:-0.00055599212646484
NPS ALLELIX CORP. Patent Filings

NPS ALLELIX CORP.

Patent Applications and Registrations

Patent applications and USPTO patent grants for NPS ALLELIX CORP..The latest application filed is for "methods useful in the treatment of bone resorption diseases".

Company Profile
0.17.25
  • NPS ALLELIX CORP. -
  • NPS Allelix Corp. - Salt Lake City UT
  • NPS Allelix Corp. - 6850 Goreway Drive Mississauga CA
  • NPS Allelix Corp - Toronto Ontario CA
  • NPS ALLELIX CORP. - Toronto CA
  • NPS Allelix, Corp. - Mississauga CA
  • NPS Allelix Corporation - Mississauga CA
  • NPS Allelix Corp. - Ontario CA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Methods Useful In The Treatment Of Bone Resorption Diseases
App 20090118192 - Dietrich; John ;   et al.
2009-05-07
Methods useful in the treatment of bone resorption diseases
Grant 7,507,715 - Dietrich , et al. March 24, 2
2009-03-24
Azaindoles Having Serotonin Receptor Affinity
App 20080004307 - Edwards; Louise ;   et al.
2008-01-03
Azaindoles having serotonin receptor affinity
Grant 7,268,127 - Edwards , et al. September 11, 2
2007-09-11
Biomarker of improved intestinal function
App 20070184554 - Teuscher; Nathan S. ;   et al.
2007-08-09
Assay system for GLP-2 receptor ligands
App 20070154959 - Demchyshyn; Lidia L. ;   et al.
2007-07-05
GLP-2 receptor gene promoter and uses thereof
App 20070033662 - Drucker; Daniel J. ;   et al.
2007-02-08
Production of human parathyroid hormone from microorganisms
App 20070010439 - Gautvik; Kaare M. ;   et al.
2007-01-11
Methods useful in the treatment of bone resorption diseases
App 20060211613 - Dietrich; John ;   et al.
2006-09-21
AMPA-binding human GluR4 receptors
Grant 7,071,306 - Kamboj , et al. July 4, 2
2006-07-04
Treatment of short bowel syndrome patients with colon-in-continuity
App 20060135424 - Sanguinetti; Elizabeth Lemaire ;   et al.
2006-06-22
GLP-2 formulations
Grant 7,056,886 - Isaacs June 6, 2
2006-06-06
Isolated human EDG-4 receptor
Grant 7,052,850 - Munroe , et al. May 30, 2
2006-05-30
AMPA-binding human GluR3 receptors
Grant 7,030,221 - Kamboj , et al. April 18, 2
2006-04-18
Methods useful in the treatment of bone resorption diseases
Grant 7,018,982 - Dietrich , et al. March 28, 2
2006-03-28
Production of human parathyroid hormone from microorganisms
Grant 6,962,796 - Gautvik , et al. November 8, 2
2005-11-08
Azaindoles having serotonin receptor affinity
App 20050239788 - Edwards, Louise ;   et al.
2005-10-27
Protein formulations
App 20050209144 - Billger, Martin ;   et al.
2005-09-22
Production of glucagon like peptide 2 and analogs
App 20050164930 - Sasaki, Ken ;   et al.
2005-07-28
Azaindoles having serotonin receptor affinity
Grant 6,916,818 - Edwards , et al. July 12, 2
2005-07-12
Method for treating bone loss using parathyroid hormone
App 20050119183 - Wells, David ;   et al.
2005-06-02
Compounds having 5-HT6 receptor antagonist activity
Grant 6,897,215 - Xin , et al. May 24, 2
2005-05-24
Stabilized formulation of parathyroid hormone
App 20050032698 - Day, David ;   et al.
2005-02-10
Arylglycine derivatives for use as glycine transport inhibitors
App 20040152740 - Isaac, Methvin ;   et al.
2004-08-05
Arylglycine derivatives and their use as glycine transport inhibitors
App 20040152741 - Isaac, Methvin ;   et al.
2004-08-05
Azaindoles having serotonin receptor affinity
App 20040132734 - Edwards, Louise ;   et al.
2004-07-08
Azaindoles having serotonin receptor affinity
Grant 6,686,374 - Edwards , et al. February 3, 2
2004-02-03
Production of human parathyroid hormone from microorganisms
App 20040005668 - Gautvik, Kaare M. ;   et al.
2004-01-08
GlyT-1 inhibitors
Grant 6,667,336 - Wang , et al. December 23, 2
2003-12-23
Methods of enhancing functioning of the large intestine
App 20030207809 - Drucker, Daniel J.
2003-11-06
Use of N-alkylamino-heterocylic compounds for the treatment of migraine
Grant 6,635,639 - Arora , et al. October 21, 2
2003-10-21
Glucagon-like peptide-2 analogs
App 20030162703 - Drucker, Daniel J. ;   et al.
2003-08-28
Methods useful in the treatment of bone resorption diseases
App 20030162716 - Dietrich, John ;   et al.
2003-08-28
Diaryl-enynes
App 20030092769 - Egle, Ian ;   et al.
2003-05-15
Modulatory proteins of human CNS receptors
App 20030087371 - Foldes, Robert L. ;   et al.
2003-05-08
Modulatory proteins of human CNS receptors
App 20030082727 - Foldes, Robert ;   et al.
2003-05-01
AMPA-binding human GluR4 receptors
App 20030053993 - Kamboj, Rajender ;   et al.
2003-03-20
Diaryl-enynes
App 20020169197 - Egle, Ian ;   et al.
2002-11-14
Diaryl-enynes
Grant 6,426,364 - Egle , et al. July 30, 2
2002-07-30
Methods useful in the treatment of bone resorption diseases
Grant 6,284,730 - Dietrich , et al. September 4, 2
2001-09-04
Bicyclic piperidine and piperazine compounds having 5-HT6 receptor affinity
Grant 6,251,893 - Maddaford , et al. June 26, 2
2001-06-26
Intestinotrophic glucagon-like peptide-2 analogs
Grant 6,184,201 - Drucker , et al. February 6, 2
2001-02-06

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed